Proteomics has emerged as a groundbreaking tool. But where are we in the evolution of these methods, and how exactly are they ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from ...

The BabySeq project was a first-of-its-kind initiative that used a randomised clinical trial format to assess the utility of genomic sequencing to identify disease risk in newborns.

This feature explores The Role of Biologists in the Age of AI Foundational Models. Find our more in our upcomind Multi-Omics ...

Currently, Illumina is comfortably the largest gene-sequencing company. But how did Illumina manage to monopolise the gene-sequencing market?

It is now possible to sequence an entire genome in just one day, due to the advent of next generation sequencing (NGS).

In our latest feature, we explore the future of gene editing and the challenges we must overcome to harness its full potential.

Advances in protein sequencing enable deeper insights and facilitate applications such as biomarker discovery and personalised medicine.

New research has uncovered the function of red blood cells as immune sensors that detect and bind to cell-free DNA present during sepsis.

A recent multi-centre study has shown the successful engineering of a strain of E. Coli Nissle 1917, designated SYNB1618 to treat Phenylketonuria (PKU).

This webinar will demonstrate how variant interpretation software can improve the accuracy and speed of variant interpretation using specific case studies.